tirzepatide compound no longer available IMPORTANT ANNOUNCEMENT Mounjaro and Zepbound Are No

There are currently around 54 million patients with a diagnosis of dementia worldwide with incidence rates predicted to triple internationally to 152 million people by 2050 and will cost health services $2 trillion a year by 2030 as per the World Alzheimer Report 2018 [3]

To manage these side effects, it's important to start with the lowest effective peptide dosing and gradually increase as tolerated

Connect with us today for our compiled data, deeper discussions about the GLP-1 market or regional biotech and pharmaceutical trends

We verify your benefits, follow up with insurers, and take care of all necessary authorizations

Text or call our office 312-846-1629 to get your free consultation today

Patients should promptly report severe or persistent abdominal pain (possible pancreatitis), persistent vomiting/diarrhea (dehydration risk), jaundice or right upper quadrant pain (gallbladder disease), neck masses/voice changes/difficulty swallowing (thyroid concerns), or visual changes (diabetic retinopathy concerns in patients with diabetes)